Clayton Robertson
Investor Relations Contact chez IMMUNOCORE HOLDINGS PLC
Profil
Clayton Robertson is currently the Head-Investor Relations at Immunocore Holdings Plc.
Previously, he worked as the Director-Investor Relations at Actinium Pharmaceuticals, Inc. from 2020 to 2021, Director-Investor Relations at PureTech Health Plc in 2020, and Investor Relations Contact at Achillion Pharmaceuticals, Inc. from 2019 to 2020.
He also worked as an Analyst at Trout Capital LLC.
Mr. Robertson completed his undergraduate degree at the University of Pennsylvania.
Postes actifs de Clayton Robertson
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Investor Relations Contact | 01/02/2021 |
Anciens postes connus de Clayton Robertson
| Sociétés | Poste | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Investor Relations Contact | 01/02/2021 |
| PURETECH HEALTH PLC | Investor Relations Contact | 01/08/2020 |
| ACHILLION PHARMACEUTICALS, INC. | Investor Relations Contact | 01/05/2020 |
Trout Capital LLC
 Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco. | Analyst-Equity | - |
Formation de Clayton Robertson
| University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| PURETECH HEALTH PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco. | Finance |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |